Combining EGFR targeted therapy with chemotherapy in pancreatic cancer: Is timing important? Journal Article
| Authors: | Riely, G. J.; Pao, W. |
| Article Title: | Combining EGFR targeted therapy with chemotherapy in pancreatic cancer: Is timing important? |
| Keywords: | cancer chemotherapy; clinical trial; erlotinib; antineoplastic agents; note; gemcitabine; pancreas cancer; pancreatic neoplasms; phase 2 clinical trial; drug administration schedule; epidermal growth factor receptor; receptor, epidermal growth factor; cancer cell culture; drug effect; cell line, tumor; cetuximab; protein tyrosine kinase inhibitor; antiinfective agent; gefitinib; phase 3 clinical trial; pancreatic cancer; quinazolines; factor receptor; epidermal growth |
| Journal Title: | Cancer Biology and Therapy |
| Volume: | 4 |
| Issue: | 10 |
| ISSN: | 1538-4047 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2005-10-01 |
| Start Page: | 1096 |
| End Page: | 1097 |
| Language: | English |
| PUBMED: | 16294020 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 2" - "Export Date: 24 October 2012" - "Source: Scopus" |
